|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo Y, Zeng H, Zheng R, Li S, Barnett AG,
Zhang S, Zou X, Huxley R, Chen W and Williams G: The association
between lung cancer incidence and ambient air pollution in China: A
spatiotemporal analysis. Environ Res. 144:60–65. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zheng X, Schipper M, Kidwell K, Lin J,
Reddy R, Ren Y, Chang A, Lv F, Orringer M and Spring Kong FM:
Survival outcome after stereotactic body radiation therapy and
surgery for stage I non-small cell lung cancer: A meta-analysis.
Int J Radiat oncol Biol Phys. 90:603–611. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sperduto PW, Yang TJ, Beal K, Pan H, Brown
PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, et al:
Estimating survival in patients with lung cancer and brain
metastases: An update of the graded prognostic assessment for lung
cancer using molecular markers (Lung-molGPA). JAMA Oncol.
3:827–831. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schewe M, Franken PF, Sacchetti A, Schmitt
M, Joosten R, Böttcher R, van Royen ME, Jeammet L, Payré C, Scott
PM, et al: Secreted phospholipases A2 are intestinal stem cell
niche factors with distinct roles in homeostasis, inflammation and
cancer. Cell Stem Cell. 19:38–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Quach ND, Arnold RD and Cummings BS:
Secretory phospholipase A2 enzymes as pharmacological targets for
treatment of disease. Biochem Pharmacol. 90:338–348. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pedada SR, Yarla NS, Tambade PJ,
Dhananjaya BL, Bishayee A, Arunasree KM, Philip GH, Dharmapuri G,
Aliev G, Putta S and Rangaiah G: Synthesis of new secretory
phospholipase A2-inhibitory indole containing isoxazole derivatives
as anti-inflammatory and anticancer agents. Eur J Med Chem.
112:289–297. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rubio JM, Rodríguez JP, Gil-de-Gómez L,
Guijas C, Balboa MA and Balsinde J: Group V secreted phospholipase
A2 is upregulated by IL-4 in human macrophages and mediates
phagocytosis via hydrolysis of ethanolamine phospholipids. J
Immunol. 194:3327–3339. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu Y, Li Y, Shang M, Jian Y, Wang C,
Bardeesi AS, Li Z, Chen T, Zhao L, Zhou L, et al: Secreted
phospholipase A2 of Clonorchis sinensis activates hepatic stellate
cells through a pathway involving JNK signalling. Parasit Vectors.
10:1472017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu W, Zhang H, Niu Y, Wu Y, Sun W, Li H,
Kong J, Ding K, Shen HM, Wu H, et al: Long non-coding RNA linc00673
regulated non-small cell lung cancer proliferation, migration,
invasion and epithelial mesenchymal transition by sponging
miR-150-5p. Mol Cancer. 16:1182017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schmidt K, Joyce CE, Buquicchio F, Brown
A, Ritz J, Distel RJ, Yoon CH and Novina CD: The lncRNA SLNCR1
mediates melanoma invasion through a conserved SRA1-like region.
Cell Rep. 15:2025–2037. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hulstaert E, Brochez L, Volders PJ,
Vandesompele J and Mestdagh P: Long non-coding RNAs in cutaneous
melanoma: Clinical perspectives. Oncotarget. 8:43470–43480. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu S and Dong Z: overexpression of
secretory phospholipase A2-IIa supports cancer stem cell phenotype
via HER/ERBB-elicited signaling in lung and prostate cancer cells.
Int J Oncol. 50:2113–2122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brglez V, Pucer A, Pungerčar J, Lambeau G
and Petan T: Secreted phospholipases A2 are
differentially expressed and epigenetically silenced in human
breast cancer cells. Biochem Biophys Res Commun. 445:230–235. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choi YA, Lim HK, Kim JR, Lee CH, Kim YJ,
Kang SS and Baek SH: Group IB secretory phospholipase A2 promotes
matrix metalloproteinase-2-mediated cell migration via the
phosphatidylinositol-3 kinase and Akt pathway. J Biol Chem.
279:36579–36585. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu Y and Wu PY: CD133 as a marker for
cancer stem cells: Progresses and concerns. Stem Cells Dev.
18:1127–1134. 2009. View Article : Google Scholar : PubMed/NCBI
|
